United Therapeutics Corporation (UTHR) financial statements (2020 and earlier)

Company profile

Business Address 1040 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,4861,4169271,051954696689
Cash and cash equivalents7386697051,023832398279
Short-term investments74874722228122298410
Receivables151176297215193162126
Inventory, net of allowances, customer advances and progress billings93101108100816748
Inventory93101108100816748
Other current assets1347511660474946
Total current assets:1,8651,7681,4481,4251,275974909
Noncurrent Assets
Property, plant and equipment739700546489496478465
Long-term investments and receivables768443503238123448
Long-term investments768443503238123448
Intangible assets, net (including goodwill), including:1581714634282914
Goodwill28321410101011
Intangible assets, net (excluding goodwill)(5)(5)(9)(9)343
Other undisclosed intangible assets, net (including goodwill)13614441321616
Restricted cash and investments      5
Deferred income tax assets230
Other noncurrent assets1552242241971549853
Deferred tax assets, net96113178193182193
Total noncurrent assets:2,0491,6331,4329019099101,179
TOTAL ASSETS:3,9133,4012,8792,3262,1841,8842,088
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1481661711041038592
Accounts payable102388877
Accrued liabilities13914316396967886
Employee-related liabilities     2827
Other undisclosed accounts payable and accrued liabilities     (28)(27)
Debt252   5067
Other liabilities40383434571025
Other undisclosed current liabilities2372240195275409504
Total current liabilities:463277445333441504688
Noncurrent Liabilities
Long-term debt and lease obligation600     4
Long-term debt, excluding current maturities600     4
Liabilities, other than long-term debt70676413114411592
Other liabilities70676413114411592
Other undisclosed noncurrent liabilities 250250    
Total noncurrent liabilities:67031731413114411596
Total liabilities:1,133593758463585619783
Temporary equity, carrying amount 191911112345
Stockholders' equity
Stockholders' equity attributable to parent2,7802,7892,1021,8511,5891,2421,259
Common stock1111111
Treasury stock, value(2,579)(2,579)(2,579)(2,380)(1,902)(1,186)(513)
Additional paid in capital2,0481,9401,8541,8141,7911,3761,057
Accumulated other comprehensive loss(14)(8)(20)(17)(20)(17)(13)
Retained earnings3,3253,4352,8462,4341,7201,068728
Total stockholders' equity:2,7802,7892,1021,8511,5891,2421,259
TOTAL LIABILITIES AND EQUITY:3,9133,4012,8792,3262,1841,8842,088

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1,4491,6281,7251,5991,4661,2891,117
Revenue, net1,7251,5991,4661,2891,117
Cost of revenue(391)(199)(315)(73)(418)(126)(131)
Cost of goods and services sold(118)(199)(106)(73)(69)(126)(131)
Other undisclosed gross profit     (9)(10)
Gross profit:1,0581,4291,4101,5261,0481,154976
Operating expenses(1,245)(624)(595)(464)(349)(625)(696)
Other undisclosed operating income     1013
Operating income (loss):(188)8058151,062699539292
Nonoperating income (expense)23(47)(45)(2)345(14)(14)
Investment income, nonoperating4429(50)   4
Other nonoperating income (expense)23(8)132041
Interest and debt expense(44)(14)(9)(4)(5)(18)(18)
Income (loss) from continuing operations before equity method investments, income taxes:(209)7457611,0561,040508261
Other undisclosed income from continuing operations before income taxes44149451818
Income (loss) from continuing operations before income taxes:(165)7597701,0601,044525279
Income tax expense (benefit)61(170)(352)(347)(393)(185)(104)
Net income (loss) available to common stockholders, diluted:(105)589418714652340175

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(105)589418714652340175
Other comprehensive income  1111 
Comprehensive income (loss):(105)589419715653342175
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6)12(4)3(5)(5)2
Comprehensive income (loss), net of tax, attributable to parent:(111)601415717648337176

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: